All News

ROCKVILLE, Md. -- Acting with uncommon speed, the FDA today approved Celebrex for the pain of juvenile rheumatoid arthritis-less than a month after an advisory committee recommended that it do so.

Carotid Stenting

NEW YORK -- Community-based interventionalists and surgeons can be trained to perform catheter-based carotid stenting in high-risk patients just as well as those who tested the devices in the studies that led to FDA approvals, researchers reported.

NEW YORK -- Community-based interventionalists and surgeons can be trained to perform catheter-based carotid stenting in high-risk patients just as well as those who tested the devices in the studies that led to FDA approvals, researchers reported.

SAN ANTONIO -- Breast cancer patients may get similar benefit with less toxicity from adjuvant chemotherapy containing Taxotere and Herceptin but not the cardiotoxic anthracycline Adriamycin, researchers said.

LUND, Sweden -- Men are more likely than women to achieve rheumatoid arthritis remission, researchers here have found.

ROCKFORD, Ill. -- Even experienced gastroenterologists may miss neoplastic lesions if they hurry through screening colonoscopies, according to a small study here.

ROCKFORD, Ill. -- Even experienced gastroenterologists may miss neoplastic lesions if they hurry through screening colonoscopies, according to a small study here.

PHILADELPHIA -- Performance measures for hospitals adopted by Medicare and the Joint Commission on Accreditation of Healthcare Organizations may only be loosely related to patient outcomes.

ORLANDO -- For preventing recurrent DVT, once-weekly idraparinux, an investigational synthetic oligosaccharide, was comparable to the combination of low-molecular-weight heparin and a daily vitamin K antagonist, Dutch researchers reported here.

ORLANDO -- An investigational oral platelet growth factor increased platelet levels in patients with chronic idiopathic thrombocytopenic purpura (ITP) reported investigators here.